Samsung’s enterprise funding unit is trying to put money into California-based medical machine startup, Exo, in a spherical that might climb to $100 million, Bloomberg reported, citing nameless sources.
The spherical is being led by Sands Capital, Bold Capital and Qubit Health Capital, the report mentioned, including that Qubit’s chairman, Imar Ishrak, would be a part of Exo’s board.
Founded in 2015, Exo makes handheld medical imaging gadgets that use a mix of synthetic intelligence, medical imaging and silicon know-how for ultrasound examinations like scanning lungs or echocardiograms. The machine plugs right into a smartphone, and health workers can scan sufferers, doc, and share examination stories utilizing one app.
The firm has up to now raised greater than $320 million in funding from buyers together with RA Capital Management, BlackRock, Sands Capital, Intel, Sony, and Avidity Partners. The firm most not too long ago raised a $220 million in Series C spherical in 2021.
Exo can also be in talks to accomplice with Samsung Medison Co., which makes medical gadgets for ultrasound diagnostics and digital X-ray programs, the report mentioned.
Exo, Samsung, Sands Capital, Bold Capital and Qubit Health didn’t instantly return requests for remark.
